Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M A Pfaller

Showing results (491-500 of 542) with videos related to

Pageof 55
Sort By:
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 30, 2000
Outbreak of severe Pseudomonas aeruginosa infections caused by a contaminated drain in a whirlpool bathtubY F Berrouane, L A McNutt, B J Buschelman, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|September 1, 1991
Antimicrobial activity of RU29246 (HR916 metabolite) compared with four other oral beta-lactams tested against more than 5000 clinical isolatesP R Murray, S D Allen, M E Erwin, et al.
Antimicrobial Agents and Chemotherapy|July 1, 1991
In vitro comparison of GR69153, a novel catechol-substituted cephalosporin, with ceftazidime and ceftriaxone against 5,203 recent clinical isolatesJ A Washington, R N Jones, S D Allen, et al.
Journal of Clinical Microbiology|May 1, 1995
Quality control guidelines for National Committee for Clinical Laboratory Standards recommended broth macrodilution testing of amphotericin B, fluconazole, and flucytosineM A Pfaller, M Bale, B Buschelman, et al.
Annals of Internal Medicine|October 1, 1992
Transmission of herpes simplex virus type 1 infection in an intensive care unitT M Perl, T H Haugen, M A Pfaller, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 26, 1999
Survey of bloodstream infections due to gram-negative bacilli: frequency of occurrence and antimicrobial susceptibility of isolates collected in the United States, Canada, and Latin America for the SENTRY Antimicrobial Surveillance Program, 1997D J Diekema, M A Pfaller, R N Jones, et al.
Antimicrobial Agents and Chemotherapy|December 31, 1998
In vitro activities of voriconazole, fluconazole, and itraconazole against 566 clinical isolates of Cryptococcus neoformans from the United States and AfricaM A Pfaller, J Zhang, S A Messer, et al.
Journal of Clinical Microbiology|July 1, 1994
Multisite reproducibility of colorimetric broth microdilution method for antifungal susceptibility testing of yeast isolatesM A Pfaller, Q Vu, M Lancaster, et al.
Infection Control and Hospital Epidemiology|November 4, 1998
An outbreak of Serratia marcescens infections related to contaminated chlorhexidineP Vigeant, V G Loo, C Bertrand, et al.
Journal of Clinical Microbiology|April 20, 2007
Results from the ARTEMIS DISK Global Antifungal Surveillance study, 1997 to 2005: an 8.5-year analysis of susceptibilities of Candida species and other yeast species to fluconazole and voriconazole determined by CLSI standardized disk diffusion testingM A Pfaller, D J Diekema, D L Gibbs, et al.
Pageof 55

Showing results (491-500 of 542) with videos related to

Sort By:
Pageof 55
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 30, 2000
Outbreak of severe Pseudomonas aeruginosa infections caused by a contaminated drain in a whirlpool bathtubY F Berrouane, L A McNutt, B J Buschelman, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|September 1, 1991
Antimicrobial activity of RU29246 (HR916 metabolite) compared with four other oral beta-lactams tested against more than 5000 clinical isolatesP R Murray, S D Allen, M E Erwin, et al.
Antimicrobial Agents and Chemotherapy|July 1, 1991
In vitro comparison of GR69153, a novel catechol-substituted cephalosporin, with ceftazidime and ceftriaxone against 5,203 recent clinical isolatesJ A Washington, R N Jones, S D Allen, et al.
Journal of Clinical Microbiology|May 1, 1995
Quality control guidelines for National Committee for Clinical Laboratory Standards recommended broth macrodilution testing of amphotericin B, fluconazole, and flucytosineM A Pfaller, M Bale, B Buschelman, et al.
Annals of Internal Medicine|October 1, 1992
Transmission of herpes simplex virus type 1 infection in an intensive care unitT M Perl, T H Haugen, M A Pfaller, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 26, 1999
Survey of bloodstream infections due to gram-negative bacilli: frequency of occurrence and antimicrobial susceptibility of isolates collected in the United States, Canada, and Latin America for the SENTRY Antimicrobial Surveillance Program, 1997D J Diekema, M A Pfaller, R N Jones, et al.
Antimicrobial Agents and Chemotherapy|December 31, 1998
In vitro activities of voriconazole, fluconazole, and itraconazole against 566 clinical isolates of Cryptococcus neoformans from the United States and AfricaM A Pfaller, J Zhang, S A Messer, et al.
Journal of Clinical Microbiology|July 1, 1994
Multisite reproducibility of colorimetric broth microdilution method for antifungal susceptibility testing of yeast isolatesM A Pfaller, Q Vu, M Lancaster, et al.
Infection Control and Hospital Epidemiology|November 4, 1998
An outbreak of Serratia marcescens infections related to contaminated chlorhexidineP Vigeant, V G Loo, C Bertrand, et al.
Journal of Clinical Microbiology|April 20, 2007
Results from the ARTEMIS DISK Global Antifungal Surveillance study, 1997 to 2005: an 8.5-year analysis of susceptibilities of Candida species and other yeast species to fluconazole and voriconazole determined by CLSI standardized disk diffusion testingM A Pfaller, D J Diekema, D L Gibbs, et al.
Pageof 55